Perspectives in Medical Research

References

1. ANTONIOLI P, MANZALINI MC, STEFANATI A, et al. Temporal trends of healthcare associated infections and antimicrobial use in 2011-2013, observed with annual point prevalence surveys in Ferrara University Hospital, Italy. Journal of Preventive Medicine and Hygiene. 2016;57(3): E135-E141.
2. Yallew WW, Kumie A, Yehuala FM. Risk factors for hospitalacquired infections in teaching hospitals of Amhara regional state, Ethiopia: A matched-case control study. Folgori L, ed. PLoS ONE. 2017;12(7): e0181145. doi:10.1371/journal.pone.0181145.
3. Solomon Ali, Melkamu Birhane, Sisay Bekele, et al. Healthcare associated infection and its risk factors among patients admitted to a tertiary hospital in Ethiopia: longitudinal study. Antimicrob Resist Infect Control. 2018; 7: 2. doi: 10.1186/s13756-017-0298-5
4. Nair V, Sahni AK, Sharma D, et al. Point prevalence & risk factor assessment for hospital-acquired infections in a tertiary care hospital in Pune, India. The Indian Journal of Medical Research. 2017;145(6):824-832. doi:10.4103/ ijmr.IJMR_1167_15.
5. Kumar A, Biswal M, Dhaliwal N, et al. Point prevalence surveys of healthcare-associated infections and use of indwelling devices and antimicrobials over three years in a tertiary care hospital in India. J Hosp Infect. 2014 Apr;86(4):272-4. doi: 10.1016/j.jhin.2013.12.010.
6. Askarian M, Yadollahi M, Assadian O. Point prevalence and risk factors of hospital acquired infections in a cluster of university-affiliated hospitals in Shiraz, Iran. J Infect Public Health. 2012 Apr;5(2):169-76. doi: 10.1016/ j.jiph.2011.12.004.
7. Zhang Y, Zhang J, Wei D, Yang Z, Wang Y, Yao Z. Annual surveys for point-prevalence of healthcare-associated infection in a tertiary hospital in Beijing, China, 2012-2014. BMC Infectious Diseases. 2016;16:161. doi:10.1186/ s12879-016-1504-4.
8. Yallew WW, Kumie A, Yehuala FM. Point prevalence of hospital-acquired infections in two teaching hospitals of Amhara region in Ethiopia. Drug, Healthcare and Patient Safety. 2016;8:71-76. doi:10.2147/DHPS.S107344.
9. Cai Y, Venkatachalam I, Tee NW, et al. Prevalence of Healthcare-Associated Infections and Antimicrobial Use Among Adult Inpatients in Singapore Acute-Care Hospitals: Results From the First National Point Prevalence Survey. Clin Infect Dis. 2017 May 15;64(suppl_2):S61-S67. doi: 10.1093/cid/cix103.
10. Balkhy HH, Cunningham G, Chew FK, Francis C, Al Nakhli DJ, Almuneef MA, Memish ZA. Hospital- and communityacquired infections: a point prevalence and risk factors survey in a tertiary care center in Saudi Arabia. Int J Infect Dis. 2006 Jul;10(4):326-33.
11. Kumar S, Sen P, Gaind R, et al. Prospective surveillance of device-associated health care-associated infection in an intensive care unit of a tertiary care hospital in New Delhi, India. Am J Infect Control. 2017 Oct 15. pii: S0196- 6553(17)31043-X. doi: 10.1016/j.ajic.2017.08.037.
12. Jahani-Sherafat S1, Razaghi M1, Rosenthal VD, et al. Device-associated infection rates and bacterial resistance in six academic teaching hospitals of Iran: Findings from the International Nosocomial Infection Control Consortium (INICC). J Infect Public Health. 2015 NovDec;8(6):553-61. doi: 10.1016/j.jiph.2015.04.028.
13. Hase R, Miyoshi K, Matsuura Y, Endo Y, Nakamura M, Otsuka Y. Legionella pneumonia appeared during hospitalization in a patient with hematological malignancy confirmed by sputum culture after negative urine antigen test. J Infect Chemother. 2018 Jan 17. pii: S1341- 321X(17)30317-3. doi: 10.1016/j.jiac.2017.12.016.
14. Kandi V. Human Nocardia Infections: A Review of Pulmonary Nocardiosis. Muacevic A, Adler JR, eds. Cureus. 2015;7(8):e304. doi:10.7759/cureus.304.
15. Stolk JM, Russcher A, van Elzakker EP, Schippers EF. [Legionella pneumonia after the use of CPAP equipment]. Ned Tijdschr Geneeskd. 2016;160:A9855.
16. Vujevic M, Benzon B, Markic J. New prediction model for diagnosis of bacterial infection in febrile infants younger than 90 days. Turk J Pediatr 2017; 59: 261-268.
17. Saptharishi LG, Jayashree M, Singhi S. Development and validation of the "Pediatric Risk of Nosocomial Sepsis (PRiNS)" score for health care-associated infections in a medical pediatric intensive care unit of a developing economy--a prospective observational cohort study. J Crit Care. 2016 Apr;32:152-8. doi: 10.1016/j.jcrc.2015.11.016.
18. Sarvikivi E, Kärki T, Lyytikäinen O; Finnish NICU Prevalence Study Group. Repeated prevalence surveys of healthcareassociated infections in Finnish neonatal intensive care units. J Hosp Infect. 2010 Oct;76(2):156-60. doi: 10.1016/ j.jhin.2010.03.020.
19. Ozkan H, Cetinkaya M, Koksal N, Celebi S, Hacimustafaoglu M. Culture-proven neonatal sepsis in preterm infants in a neonatal intensive care unit over a 7 year period: coagulase-negative Staphylococcus as the predominant pathogen. Pediatr Int. 2014 Feb;56(1):60-6. doi: 10.1111/ ped.12218.
20. Caggiano G, Lovero G, De Giglio O, et al. Candidemia in the Neonatal Intensive Care Unit: A Retrospective, Observational Survey and Analysis of Literature Data. BioMed Research International. 2017;2017:7901763. doi:10.1155/2017/7901763.
21. Brosio F, Kuhdari P, Stefanati A, et al. Knowledge and behaviour of nursing students on the prevention of healthcare associated infections. Journal of Preventive Medicine and Hygiene. 2017;58(2):E99-E104.
22. Musu M, Lai A, Mereu NM, et al. Assessing hand hygiene compliance among healthcare workers in six Intensive Care Units. Journal of Preventive Medicine and Hygiene. 2017;58(3):E231-E237.
23. Stahmeyer JT, Lutze B, von Lengerke T, Chaberny IF, Krauth C. Hand hygiene in intensive care units: a matter of time? J Hosp Infect. 2017 Apr;95(4):338-343. doi: 10.1016/ j.jhin.2017.01.011.
24. Strich JR, Palmore TN. Preventing Transmission of Multidrug-Resistant Pathogens in the Intensive Care Unit. Infect Dis Clin North Am. 2017 Sep;31(3):535-550. doi: 10.1016/j.idhttps://www.ncbi.nlm.nih.gov/pmc/articles/ PMC3895323/c.2017.05.010.
25. Derde LPG, Cooper BS, Goossens H, et al. Interventions to reduce colonisation and transmission of antimicrobialresistant bacteria in intensive care units: an interrupted time series study and cluster randomised trial. The Lancet Infectious Diseases. 2014;14(1):31-39. doi:10.1016/S1473- 3099(13)70295-0.
26. Bearman GM, Marra AR, Sessler CN, et al. A controlled trial of universal gloving versus contact precautions for preventing the transmission of multidrug-resistant organisms. Am J Infect Control. 2007 Dec;35(10):650-5.
27. Verbeek JH1, Ijaz S, Mischke C, et al. Personal protective equipment for preventing highly infectious diseases due to exposure to contaminated body fluids in healthcare staff. Cochrane Database Syst Rev. 2016 Apr 19;4:CD011621. doi: 10.1002/14651858.CD011621.pub2.
28. Garibaldi BT, Chertow DS. High-Containment Pathogen Preparation in the Intensive Care Unit. Infect Dis Clin North Am. 2017 Sep;31(3):561-576. doi: 10.1016/ j.idc.2017.05.008.
29. Ghirardi B, Pietrasanta C, Ciuffini F, et al. [Management of outbreaks of nosocomial pathogens in neonatal intensive care unit]. Pediatr Med Chir. 2013 NovDec;35(6):263-8.